Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


A Risk Based Approach: Data Integrity Specialist Conference 2018

Data Integrity & Records

Add this event to your calendar: iCal   Google Calendar

Who should attend?

VP of IT Director of IT Quality Managers Project Managers (for CSV / IT) Validation Specialists Database Administrators System Administrators Directors / Senior Directors of Discovery Directors / Senior Directors of Development Directors / Senior Directors of Commercialization Document Managers Training Managers Regulators Vendors Suppliers Outsource Service Providers


Overview: The impact of Data Integrity issues on a regulated company can be significant: it can result in recalls of products, warning or untitled letters, import alerts, injunctions, seizures, legal action, etc. These regulatory actions can have significant financial impact to the company. However, and most importantly, data integrity issues can lead to potential patient harm!!Defined by the Medicines and Healthcare Products Regulatory Agency (MHRA) as "the extent which all data are complete, consistent and accurate throughout the data lifecycle", data integrity is increasingly the focus of regulatory agencies round the world. Companies must now ensure that they are appropriately addressing data integrity and data governance. This includes organizational, procedural and technical controls that must be considered as part of an overarching data governance system. In addition, the effort and resources committed to data integrity must be commensurate with the role it plays in assuring product quality.To ensure Data Integrity, a GxP regulated company needs to abide by principles, current regulations and industry best practices on the expectations for the management GxP regulated records and data. These principles, regulations and best practices, ensure that data is complete, consistent, accurate, secure and available throughout the record life cycle. This approach is intended to encourage innovation and technological advances while avoiding unacceptable risk to product quality, patient safety and public health.Key implementation considerations for a corporate data integrity program, include development of a high-level strategy, identifying and gaining executive sponsorship, focusing on management accountability, implementing tools for knowledge sharing and developing and providing the appropriate levels of training. An effective data integrity program includes addressing of behavioral factors and drives a strategy that focuses on prevention, detection, response and continuous improvement.The Seminar:This Seminar addresses the integrity of GxP records and data used within the regulated industries including pharmaceutical, biological, medical devices, cosmetics, food and any other industry where data integrity is important. It provides a method for managing risk to record and data integrity. Learning Objectives for the seminar include:• Data Integrity Requirements• Critical Areas of Regulatory Focus and Concern• Key Concepts• A Framework for Data Governance and Human Factors• A Complete Data Life Cycle Approach as Part of a Quality Management System, from Creation to Destruction• How to Apply Risk Management to Data IntegrityWhy you should attend:• VP of IT• Director of IT• Quality Managers• Project Managers (for CSV / IT)• Validation Specialists• Database Administrators• System Administrators• Directors / Senior Directors of Discovery• Directors / Senior Directors of Development• Directors / Senior Directors of Commercialization• Document Managers• Training Managers• Regulators• Vendors• Suppliers• Outsource Service ProvidersIndustries:• Pharmaceuticals• Biotech• Medical Device• Radiological Health• Blood Products• Companion Animals• Food• Cosmetics• Tobacco• AcademiaLocation: Washington DC Date: April 19th & 20th, 2018 and Time: 9:00 AM to 6:00 PMVenue: Courtyard Arlington Crystal City/Reagan National Airport 2899 Jefferson Davis Highway Arlington, VA 22202 USAPrice:Register now and save $200. (Early Bird)Price: $1,295.00 (Seminar Fee for One Delegate)Until March 10, Early Bird Price: $1,295.00 From March 11 to April 17, Regular Price: $1,495.00Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminarAt this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry. As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants. For More Information- Contact us today!NetZealous LLC DBA Toll free: +1-800-447-9407Phone: +1-510-584-9661 Website: http://www.globalcompliancepanel.comRegistration Link - us on LinkedIn: us our Facebook page: us on Twitter:


Register now and save $200. (Early Bird) Price: $1,295.00 (Seminar Fee for One Delegate) Until March 10, Early Bird Price: $1,295.00 From March 11 to April 17, Regular Price: $1,495.00 Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)* Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*


John Robinson

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.